Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers

References

• Chen M, Xia B, Chen B, et al. N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulfasalazine in the treatment of inflammatory bowel disease. Can J Gastroenterol Hepatol. 2007;21:1–9.
   Google Scholar
• Yuliwulandari R, Susilowati RW, Wicaksono BD, et al. NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis. J Hum Genet. 2016;61:533–537.
   PubMed Web of Science ®Google Scholar
• Fuselli S, Gilman R, Chanock S, et al. Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity. Pharmacogenomics J. 2007;7:144–152.
   Web of Science ®Google Scholar
• Shenfield GM. Genetic polymorphisms, drug metabolism and drug concentrations. Clin Biochem Rev. 2004;25:203.
   PubMedGoogle Scholar
• Garcia-Martin E. Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms. Curr Drug Metab. 2008;9:487–497.
   PubMed Web of Science ®Google Scholar
• Gil J, Lechner M. Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2* 4 homozygotes in Portuguese patients with colorectal cancer. Carcinogenesis. 1998;19:37–41.
   PubMed Web of Science ®Google Scholar
• Gunnarsson I, Kanerud L, Pettersson E, et al. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Rheumatology. 1997;36:1089–1094.
   Web of Science ®Google Scholar
• Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000;9:29–42.
   PubMed Web of Science ®Google Scholar
• Teixeira RLF, Silva FP, Silveira AR, et al. Sequence analysis of NAT2 gene in Brazilians: identification of undescribed single nucleotide polymorphisms and molecular modeling of the N-acetyltransferase 2 protein structure. Mutat Res Fund Mol Mech Mut. 2010;683:43–49.
   Web of Science ®Google Scholar
• Zabost A, Brzezińska S, Kozińska M, et al. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients. Biomed Res. 2013;853602. DOI:10.1155/2013/853602
   Web of Science ®Google Scholar
• Jarrar Y, Ismail S, Irshaid Y. N-acetyltransferase-2 (NAT2) genotype frequency among Jordanian volunteers. Int J Clin Pharmacol Ther. 2010;48:688–694.
   Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191.
   PubMed Web of Science ®Google Scholar
• Nurpeisov V, Hurwitz SJ, Sharma PL. Fluorescent dye terminator sequencing methods for quantitative determination of replication fitness of human immunodeficiency virus type 1 containing the codon 74 and 184 mutations in reverse transcriptase. J Clin Microbiol. 2003;41:3306–3311.
   Web of Science ®Google Scholar
• Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 1988;16:10881–10890.
   PubMed Web of Science ®Google Scholar
• Benson DA, Cavanaugh M, Clark K, et al. GenBank. Nucleic Acids Res. 2013;41(D1):36–42.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265.
   PubMed Web of Science ®Google Scholar
• Lee S-J, Kim W-Y, Choi J-Y, et al. Identification of CYP19A1 single-nucleotide polymorphisms and their haplotype distributions in a Korean population. Am J Hum Genet. 2010;55:189–193.
   Google Scholar
• Lee SS, Jeong H-E, Yi J-M, et al. Identification and functional assessment of BCRP polymorphisms in a Korean population. Drug Metab Dispos. 2007;35:623–632.
   Web of Science ®Google Scholar
• Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–1081.
   PubMed Web of Science ®Google Scholar
• Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–249.
   PubMed Web of Science ®Google Scholar
• Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph Model. 1996;14:33–38.
   Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res. 2000;28:235–242.
   PubMed Web of Science ®Google Scholar
• Thorisson GA, Smith AV, Krishnan L, et al. The international HapMap project web site. Genome Res. 2005;15:1592–1593.
   PubMed Web of Science ®Google Scholar
• Hamdy SI, Hiratsuka M, Narahara K, et al. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR‐1 in the Egyptian population. Br J Clin Pharmacol. 2003;55:560–569.
   PubMed Web of Science ®Google Scholar
• Bu R, Gutierrez M, Al-Rasheed M, et al. Variable drug metabolism genes in Arab population. Pharmacogenomics J. 2004;4:260–266.
   PubMed Web of Science ®Google Scholar
• Iohom G, Fitzgerald D, Cunningham A. Principles of pharmacogenetics—implications for the anaesthetist. Br J Anaesth. 2004;93:440–450.
   Web of Science ®Google Scholar
• Cho S-A, Rohn-Glowacki KJ, Jarrar YB, et al. Analysis of genetic polymorphism and biochemical characterization of a functionally decreased variant in prostacyclin synthase gene (CYP8A1) in humans. Arch Biochem Biophys. 2015;569:10–18.
   Web of Science ®Google Scholar
• Irshaid YM, Abujbara MA, Ajlouni KM, et al. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus. Int J Clin Pharmacol Ther. 2013;51:593–599.
   Web of Science ®Google Scholar
• Kristensen VN, Kelefiotis D, Kristensen T, et al. High-throughput methods for detection of genetic variation. Biotechniques. 2001;30:318–333.
   PubMed Web of Science ®Google Scholar
• Didone A, Nardinelli L, Marchiani M, et al. Comparative study of different methodologies to detect the JAK2 V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms. Pract Lab Med. 2016;4:30–37.
   Google Scholar
• Tanahashi T, Kita M, Kodama T, et al. Comparison of PCR-restriction fragment length polymorphism analysis and PCR-direct sequencing methods for differentiating Helicobacter pylori ureB gene variants. J Clin Microbiol. 2000;38:165–169.
   Web of Science ®Google Scholar
• Hubáček JA, Pikhart H, Peasey A, et al. Nobody is perfect: comparison of the accuracy of PCR-RFLP and KASP™ method for genotyping. ADH1B and FTO polymorphisms as examples. Folia Biol (Praha). 2015;61:156–160.
   Web of Science ®Google Scholar
• Aquilante CL, Lobmeyer MT, Langaee TY, et al. Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory. Pharmacotherapy. 2004;24:720–726.
   Web of Science ®Google Scholar
• Ma MK, Woo MH, Mcleod HL. Genetic basis of drug metabolism. Am J Health Syst Pharm. 2002;59:2061–2069.
   PubMed Web of Science ®Google Scholar
• Hein DW, Doll MA. Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. Pharmacogenomics. 2012;13:31–41.
   PubMed Web of Science ®Google Scholar
• Matejcic M, Vogelsang M, Wang Y, et al. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study. BMC Cancer. 2015;15:150.
   Web of Science ®Google Scholar
• Zihlif M, Imraish A, Irshaid YM. Frequency of certain single-nucleotide polymorphisms and duplication of CYP2D6 in the Jordanian population. Genet Test Mol Biomarkers. 2012;16:1201–1205.
   PubMed Web of Science ®Google Scholar
• Gross M, Kruisselbrink T, Anderson K, et al. Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol Biomarkers Prev. 1999;8:683–692.
   PubMed Web of Science ®Google Scholar
• Irshaid Y, al‐Hadidi H, Abuirjeie M, et al. N‐acetylation phenotyping using dapsone in a Jordanian population. Br J Clin Pharmacol. 1991;32:289–293.
   Web of Science ®Google Scholar
• Rajasekaran M, Abirami S, Chen C. Effects of single nucleotide polymorphisms on human N-acetyltransferase 2 structure and dynamics by molecular dynamics simulation. PLoS One. 2011;6:e25801.
   PubMed Web of Science ®Google Scholar
• Jarrar YB, Lee S-J. Molecular functionality of CYP2C9 polymorphisms and their influence on drug therapy. Drug Metabol Drug Interact. 2014;29:211–220.
   PubMedGoogle Scholar